We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$87.8M
AUM Growth
-$35.8M
Cap. Flow
-$37.4M
Cap. Flow %
-42.62%
Top 10 Hldgs %
58.31%
Holding
59
New
Increased
Reduced
40
Closed
12

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 46%
2 Technology 39.72%
3 Miscellaneous 3.85%
4 Financials 2.7%
5 Consumer Discretionary 2.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
1
NeoGenomics
NEO
$2.39B
$7.18M 8.18%
327,438
-68,889
-17% -$1.51M
TWLO icon
2
Twilio
TWLO
$37.1B
$6.69M 7.62%
49,044
-16,635
-25% -$2.22M
VCEL icon
3
Vericel Corp
VCEL
$2.11B
$5.99M 6.82%
317,079
-73,995
-19% -$1.26M
CY
4
DELISTED
Cypress Semiconductor
CY
$5.53M 6.3%
248,494
-67,312
-21% -$1.22M
UPLD icon
5
Upland Software
UPLD
$13.7M
$5.04M 5.74%
11,061
-2,745
-20% -$1.26M
CYBR
6
DELISTED
CyberArk
CYBR
$4.78M 5.44%
37,383
-10,161
-21% -$1.29M
OMCL icon
7
Omnicell
OMCL
$1.52B
$4.17M 4.75%
48,428
-12,638
-21% -$1.03M
ATRC icon
8
AtriCure
ATRC
$2.51B
$4.02M 4.58%
134,696
-37,273
-22% -$1.09M
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.9M 4.44%
162,142
-40,385
-20% -$1.02M
PODD icon
10
Insulet
PODD
$9.95B
$3.9M 4.44%
32,629
-3,956
-11% -$406K
FIVN icon
11
FIVE9
FIVN
$2.58B
$3.62M 4.13%
70,614
-18,212
-21% -$924K
MXL icon
12
MaxLinear
MXL
$5.75B
$3.4M 3.88%
145,212
-36,544
-20% -$890K
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.07M 3.5%
24,080
-5,510
-19% -$793K
XENT
14
DELISTED
Intersect ENT, Inc
XENT
$3.02M 3.45%
132,924
-28,184
-17% -$760K
SUPN icon
15
Supernus Pharmaceuticals
SUPN
$2.57B
$2.56M 2.92%
77,392
-22,583
-23% -$774K
FNSR
16
DELISTED
Finisar Corp
FNSR
$2.36M 2.69%
103,348
-31,957
-24% -$732K
CVLT icon
17
Commault Systems
CVLT
$5.82B
$2.09M 2.38%
42,180
-13,248
-24% -$704K
LGND icon
18
Ligand Pharmaceuticals
LGND
$5.67B
$1.63M 1.85%
22,864
-7,899
-26% -$582K
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$1.3M 1.49%
4,450
AAPL icon
20
Apple
AAPL
$4.59T
$889K 1.01%
17,976
-11,368
-39% -$554K
MAR icon
21
Marriott International
MAR
$92.3B
$740K 0.84%
5,276
-3,218
-38% -$427K
AFL icon
22
Aflac
AFL
$58.4B
$701K 0.8%
12,798
-7,529
-37% -$388K
PG icon
23
Procter & Gamble
PG
$333B
$643K 0.73%
5,866
-3,576
-38% -$381K
QQQ icon
24
Invesco QQQ Trust
QQQ
$493B
$640K 0.73%
3,425
JPM icon
25
JPMorgan Chase
JPM
$942B
$612K 0.7%
5,477
-3,450
-39% -$380K

Similar funds

Kopp Investment Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Kopp Investment Advisors held 59 positions worth $87.8M, down 29% from $124M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Kopp Investment Advisors withdrew a net $37.4M in Q2 2019, closing 12 positions and reducing 40 holdings. Its most notable exit was Integrated Device Technology I, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Miscellaneous.

  • Kopp Investment Advisors's biggest Q2 2019 reduction was Twilio, cutting an estimated $2.22M.
  • Kopp Investment Advisors fully exited Integrated Device Technology I in Q2 2019, selling an estimated $5.42M.
  • Kopp Investment Advisors's ten largest holdings make up 58% of its $87.8M portfolio in Q2 2019.
  • Kopp Investment Advisors opened 0 new positions and closed 12 in Q2 2019.
  • Kopp Investment Advisors's portfolio value fell 29% quarter-over-quarter to $87.8M.

Based on Kopp Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.